Quality Improvement Collaborative Leadership
Todd Alonso, MD, is a Pediatric Endocrinologist at the Barbara Davis Center for Childhood Diabetes, where he serves as the Assistant Medical Director for Quality and Access. His primary academic interest is improving outpatient diabetes care delivery, and he chairs the T1D Exchange Quality Improvement Collaborative IT subcommittee. Dr. Alonso is also the Medical Director for the American Diabetes Association’s Camp Colorado.
Mark Clements, MD, PhD, is an Associate Professor of Pediatrics at The University of Missouri-Kansas City School of Medicine in Missouri. At Children’s Mercy Kansas City, Dr. Clements serves as Director of Endocrine/ Diabetes Research, Medical Director for the Pediatric Clinical Research Unit, and Co-PI of the TrialNet clinical center. In addition, he has served as the Pediatric Vice-Chair for the T1D Exchange Clinic Registry and currently serves as one of the data science leaders for the T1D Exchange Quality Improvement Collaborative. Independent of those roles, he serves as Chief Medical Officer for Glooko, inc.
Sarah D. Corathers, MD, is Director of the Diabetes Transition Program, Division of Endocrinology and Director of the Quality Scholars Program at the James M. Anderson Center for Health Systems Excellence of the Cincinnati Children’s Hospital Medical Center. Dr. Corathers also is an Assistant Professor at the University of Cincinnati Department of Pediatrics.
Daniel DeSalvo, MD, is a faculty member and the Director of Strategic Collaboration in Pediatric Diabetes and Endocrinology at Baylor College of Medicine/Texas Children’s Hospital. As a sophomore in college, his life changed forever when he was diagnosed with type 1 diabetes. As a clinician and researcher, his greatest passion is helping others live well with diabetes! He is a member of the Alpha Omega Alpha Honor Medical Society and Gold Humanism Honor Society.
Satish Garg, MBBS, MD, DM, is Professor of Medicine and Pediatrics and director of the Adult Clinic of the Barbara Davis Center for Diabetes of the University of Colorado School of Medicine in Denver, Colorado. Dr. Garg has served as the Editor in Chief of Diabetes Technology and Therapeutics Journal since 2006, and as the director of ATDC Diabetes Conference in Keystone since 2005. He is an international lecturer and speaker, and serves on the editorial boards for many diabetes journals globally. He has published extensively (>300) peer-reviewed manuscripts.
Manmohan K. Kamboj, MD, is the Section Chief and Interim Division Chief of the Section of Endocrinology in the Department of Pediatrics at Nationwide Children’s Hospital and a Clinical Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Kamboj is the Director of Quality Improvement for the section of Endocrinology, and leads multiple Quality Improvement initiatives. She also serves as the PI for the T1D Exchange Quality Improvement Collaborative.
Joyce M. Lee, MD, MPH, is the Robert P. Kelch Research Professor of Pediatrics, Associate Chief Medical Information Officer for Pediatric Research, and Associate Chair for Health Metrics and Learning Health Systems at the University of Michigan. She serves as Quality Improvement Director for the Pediatric Diabetes Clinic at the University of Michigan. A Pediatric Translational Researcher with a unique mix of formal training in pediatric endocrinology, pediatric health services research and public health, Dr. Lee serves as one of the lead physician scientists with the T1D Exchange Quality Improvement Collaborative.
Ilona Lorincz, MD, MSHP, is an Assistant Professor of Clinical Medicine, Director of Quality for the Division of Endocrinology, Diabetes, and Metabolism at the Hospital of the University of Pennsylvania, and a Junior Research fellow at the Leonard Davis Institute for Health Economics. Her primary clinical interests are diabetes, thyroid disorders, transgender medicine, and improving healthcare delivery for patients with endocrine conditions.
Priya Prahalad, MD, PhD, is a Clinical Assistant Professor of Pediatrics in the Department of Endocrinology and Diabetes at Stanford University. Dr. Prahalad also is a member of Stanford’s Maternal & Child Health Research Institute (MCHRI). Previously, she served as a Pediatric Endocrinology Fellow at UCSF Medical Center.
Berhane Seyoum, MD, MPH, is a practicing Endocrinologist, Associate Professor of Medicine at Wayne State University School of Medicine, in Detroit, MI. Dr. Seyoum graduated from Addis Ababa University Faculty of Medicine in 1987 and has been in practice for 32 years. He completed residency at New York Methodist Hospital and endocrinology fellowship at Wayne State University. He currently practices at Wayne State University Physician Group which is affiliated with DMC hospitals and VA.
Ruth S. Weinstock, MD, PhD, is Division Chief of Endocrinology, Diabetes and Metabolism at SUNY Upstate Medical University, as well as Medical Director of the Clinical Research Unit and the Joslin Diabetes Center at Upstate which she helped establish in 1995. She received her MD and PhD degrees from Columbia University College of Physicians & Surgeons, and received the American Diabetes Association Outstanding Physician Clinician in Diabetes Award in 2017 and the American College of Physicians Samuel Eichold II Memorial Award for Contributions in Diabetes in 2019.
Jennifer Wyckoff, MD, is an Associate Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes Division at the University of Michigan. She serves as the Medical Director for the Adult Diabetes Education Program and the Director of the Pre-Pregnancy Diabetes Clinic for women with diabetes who wish to conceive within 6 to 12 months. Her clinical and research interests include various aspects of diabetes, including insulin pumps, patient education, and diabetes and pregnancy.
Want to Join the Collaborative?
T1D Exchange is actively recruiting new clinics to grow our QIC network of talented, experienced providers who care deeply about treatment and outcomes for people with type 1 diabetes. Participation may involve data sharing, consulting and strategizing with clinical partners across the United States. For more information about joining, please fill out our form and a representative will get in touch with you.
What Need does QIC Meet?
Most new, market-approved treatments and devices only have data about their effectiveness within the confines of a formal study; this data is insufficient to fully guide providers in a real-world setting. QIC clinics fill this gap by conducting studies and gathering information during their daily practice that can provide evidence about the effectiveness of a treatment strategy or intervention at a population level, as well as compare its performance to other strategies or interventions.